WallStSmart

Spotify Technology SA (SPOT)vsSurgepays Inc (SURG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Spotify Technology SA generates 30070% more annual revenue ($17.19B vs $56.96M). SPOT leads profitability with a 12.9% profit margin vs -63.3%. SURG appears more attractively valued with a PEG of 0.53. SPOT earns a higher WallStSmart Score of 60/100 (C+).

SPOT

Buy

60

out of 100

Grade: C+

Growth: 8.0Profit: 8.0Value: 3.3Quality: 7.5
Piotroski: 4/9Altman Z: 2.66

SURG

Hold

39

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 6.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

SPOTSignificantly Overvalued (-47.4%)

Margin of Safety

-47.4%

Fair Value

$330.58

Current Price

$443.57

$112.99 premium

UndervaluedFair: $330.58Overvalued

Intrinsic value data unavailable for SURG.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

SPOT4 strengths · Avg: 9.5/10
Return on EquityProfitability
31.9%10/10

Every $100 of equity generates 32 in profit

EPS GrowthGrowth
213.9%10/10

Earnings expanding 213.9% YoY

Market CapQuality
$106.65B9/10

Large-cap with strong market position

Debt/EquityHealth
0.289/10

Conservative balance sheet, low leverage

SURG2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
68.7%10/10

Revenue surging 68.7% year-over-year

PEG RatioValuation
0.538/10

Growing faster than its price suggests

Areas to Watch

SPOT3 concerns · Avg: 3.3/10
PEG RatioValuation
2.174/10

Expensive relative to growth rate

Price/BookValuation
9.3x4/10

Trading at 9.3x book value

P/E RatioValuation
42.2x2/10

Premium valuation, high expectations priced in

SURG4 concerns · Avg: 2.3/10
Market CapQuality
$12.91M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-314.3%2/10

ROE of -314.3% — below average capital efficiency

EPS GrowthGrowth
-77.7%2/10

Earnings declined 77.7%

Free Cash FlowQuality
$-3.56M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : SPOT

The strongest argument for SPOT centers on Return on Equity, EPS Growth, Market Cap.

Bull Case : SURG

The strongest argument for SURG centers on Revenue Growth, PEG Ratio. Revenue growth of 68.7% demonstrates continued momentum. PEG of 0.53 suggests the stock is reasonably priced for its growth.

Bear Case : SPOT

The primary concerns for SPOT are PEG Ratio, Price/Book, P/E Ratio. A P/E of 42.2x leaves little room for execution misses.

Bear Case : SURG

The primary concerns for SURG are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

SPOT profiles as a value stock while SURG is a hypergrowth play — different risk/reward profiles.

SPOT carries more volatility with a beta of 1.70 — expect wider price swings.

SURG is growing revenue faster at 68.7% — sustainability is the question.

SPOT generates stronger free cash flow (834M), providing more financial flexibility.

Bottom Line

SPOT scores higher overall (60/100 vs 39/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Spotify Technology SA

COMMUNICATION SERVICES · INTERNET CONTENT & INFORMATION · USA

Spotify Technology SA, provides audio streaming services worldwide. The company is headquartered in Luxembourg, Luxembourg.

Surgepays Inc

COMMUNICATION SERVICES · TELECOM SERVICES · USA

SurgePays, Inc., provides telecommunications services in the United States. The company is headquartered in Bartlett, Tennessee.

Want to dig deeper into these stocks?